According to Cleveland BioLabs 's latest financial reports the company's current earnings (TTM) are -$2.76 M. .
Year | Earnings | Change |
---|
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Novartis NVS | $9.43 B | -342,980.81% | ๐จ๐ญ Switzerland |
Eli Lilly LLY | $6.55 B | -238,227.42% | ๐บ๐ธ USA |
Amgen AMGN | $7.85 B | -285,470.71% | ๐บ๐ธ USA |
Sanofi SNY | $8.39 B | -305,101.16% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $8.44 B | -306,723.65% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $7.53 B | -273,845.89% | ๐ฌ๐ง UK |
Soligenix SNGX | -$7.79 M | 182.90% | ๐บ๐ธ USA |
OPKO Health
OPK | -$0.19 B | 6,596.28% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$20.19 M | 633.28% | ๐บ๐ธ USA |